medigraphic.com
ISSN 1561-2937 (Impreso)

2021, Número 3

<< Anterior

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (3)


Historia y evolución de hemodinámica y cardiología intervencionista

Obregón SÁG, Aroche AR, López FL, Aldama PLI, Aguilar MJM, Vila GEE

Idioma: Español
Referencias bibliográficas: 55
Paginas: 1-9
Archivo PDF: 417.15 Kb.


FRAGMENTO

No hay ninguna especialidad en la historia de la medicina que haya evolucionado tan rápido como la cardiología intervencionista como consecuencia de combinarse la necesidad de obtener mejores resultados en el tratamiento de la enfermedad coronaria (EC), primera causa de muerte a nivel mundial y la perseverancia en buscar nuevas técnicas de algunos investigadores notables.
Se considera que el primer procedimiento terapéutico de cardiología intervencionista fue en 1963 en una arteria periférica y en 1977 con la primera angioplastia coronaria. A partir de ese momento ha evolucionado, de tal manera que en el momento actual en la práctica médica la angioplastia coronaria es uno de los procedimientos que más se realizan a nivel mundial.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Forssmann W. The catheterization of the right side of the Heart. Klin Wochenschr 1929; 8: 2085-9.

  2. Klein O. Determining human cardiac output (minute volume) using Fick’s principle (extraction of mixed venous blood by cardiac catheterization) Med Wochenschr 1930; 77:1311-5.

  3. Castellanos A, Pereiras R., Garcia A. Counter-Part aortography. Rev Cuban Cardiol 1939; 2:187-9.

  4. Cournand A , Ranges HA. Catheterization of the right auricle in man. Proc Soc Exp Biol Med 1941; 46: 462.

  5. Brannon ES, Weens HS, Warren JW, Atrial septal defect: Study of hemodynamics by the technique of right heart catheterization. Am J Med Sci 1945; 210:480- 9.

  6. Zimmerman HA, Scott RW, Becker NO. Catheterization of the left side of the heart in man. Circulation 1950; 1-357-61.

  7. Dotter CT, Frische LH. Visualization of the coronary circulation by occlusion aortography: a practical method. Radiology 1958; 76:502-7.

  8. Arnulf G, Chacornac R. Communication to La Société de Chirurgie de Lyon, Novembre 14, 1957, in Arnulf G. L’artériographie méthodique des artères coronaries grâce a l’utilisation de l’acétylcholine: Données expérimentales et cliniques. Bull Acad Natl Med (Paris) 1958 ; 25/26 :661-3.

  9. Richard LS, Thal AP. Phasic dye injection control system for coronary arteriography in the human. Surg Gynecol Obstet 1958; 107:739-43.

  10. Nordenstrom B. Contrast examination of the cardiovascular system during increased intrabronchial pressure. Acta Radiol1960; 200 Suppl: 110-5.

  11. Bilgutay AM, Gannon P, Sterns LP. Ferlic R, Lillehei CW. Coronary arteriography: New method under induced hypotension by pacing_ experimental and clinical application. Arch Surg 1964; 89:899-01.

  12. Bellman S, Frank HA, Lambert PB, Littman D, Williams JA. Coronary arteriography: I. Differential opacification of the aortic stream catheters of special design: Experimental development. N Engl J Med 1960; 262:325-9.

  13. Sones FM. Coronary arteriography. Read before the Eighth Annual Convention of the American College of Cardiology, Philadelphia, 1959.

  14. Dotter CT, Judkins MP. Transluminal treatment of atherosclerotic obstruction: Description of a new technique and preliminary report of its application. Circulation 1964; 30:654-8.

  15. Dotter CT, Rosch J, Judkins MP. Transluminal dilatation of atherosclerotic stenosis. Surg Gynecol Obstet 1968; 127:794-8.

  16. Gruentzig AR, Turina M, Schneider J. Experimental percutaneous dilatation of coronary artery stenosis. Circulation Suppl 1976; 54:81-5.

  17. Hurst J.W. History of cardiac catheterization. In. King SB III, Douglas JS editors. Coronary Arteriography and Angioplasty. New York: Mc Graw - Hill 1985.p.1-9.

  18. Busch U, Erbel R, Clas W. Verbersserete Okklusiontoleranzzeit durch Kontinuierliche Koronarperfusion mit modifiziertem. Gruentzig-Koronarangioplastiekatheter Z. Kardiol 1985; 74: 435-9.

  19. Van Tassel RA, Gobel FL, Rydel MA, Vlodaver Z, McCarter DJ. A less traumatic catheter for coronary arteriography. Cathet Cardiovasc Diagn 1985;11:187-99

  20. Bonzel TR, Wollschlager H, Just H. Ein neves kathetersystem zur mechanischen dilatation von koronarstenosen mit austauschbaren intra koronaren kathetern, hoherenn kontrastmi ttelfluss und verbesserter steverbarkeit. Biomed Technn. 1986:31; 195-200.

  21. Meyer J, Merx W. Schmitz H. Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 1982; 66:905-13.

  22. Hartzler GO. Rutherford BD, Mc Conahay DR. Percutaneous transluminal coronary angioplasty with and without thrombotic therapy for treatment of acute myocardial infarctions. Am. Heart J 1983;106 : 965-71.

  23. Simpson JB, Johnson DE, Thapliyal HV. Transluminal atherectomy: a new approach to the treatment of atherosclerotic vascular disease. Circulation 1985; 72:146-53.

  24. Ritchie J, Hansen D, Urocko R. Auth D. Mechanical thrombolysis: A new rotational catheter approach for acute thrombi. Circulation 1986; 73:1006-12.

  25. Litvack F, Groundfest W, Goldenberg T. Laudenslagert J. Forrester J. Percutaneous excimer laser angioplasty of aortocoronary saphenous vein grafts J Am Coll Cardiol 1989: 14: 803-8.

  26. King III SB, Yeh W, Hulubkou R, Baim DS, Sopko G, Holmes D. Balloon angioplasty versus new device intervention clinical outcomes. J Am Coll Cardiol 1998; 31: 558-66.

  27. Mulliken JB, Goldwyn RM. Impressions of Charles Stent. Plastic Reconst Surg, 1978; 62:173-6.

  28. Palmaz JC, Sibbit RR, Reuter SR, Rice W. Expandable intraluminal graft: a preliminar study radiology;1985 156:73-7.

  29. Roubin GS, Robinson KA, King SB III, Gianturco C, Black AJ, Brown JE, et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation; 1987:891-97.

  30. Kuntz, RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993; 21:15-25.

  31. Puel J, Joffre F, Rousseau H, Guermunprez B, Lancelin B, Morice MC. Endoprothéses coronariennes auto - expansives dans le prévention des restenoses après angioplastie transluminale. Arch. Mal. Coeur1987 ; 8 : 1311-2.

  32. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987; 316:701-6.

  33. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent: Initial results of a multicenter study. Circulation 1991; 83:148-61.

  34. Roubin GS, Cannon Ad, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J, Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-27.

  35. Barragan P, Sainson J, Silvestri M . Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994; 32:133-8.

  36. Colombo A, Hall P, Nakamura S. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91:1676-88.

  37. Chornos NA, Robinson KA, Nelly AB. Thromboresistant phosphorylcholine coating for coronary stent. Circulation 1995; 92(suppl I):1-685.

  38. Foerst J, Vorpahl M, Engelhardt M, Koehler T, Tiroch K, Wessely R. Evolution of Coronary Stents: From Bare-Metal Stents to Fully Biodegradable, Drug-Eluting Stents. Comb Prod Ther. 2013;3(1–2):9–24. https://link.springer.com/article/10.1007/s13556-013-0005-7

  39. Burke SE, Lubbers NL, Chen YW. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J Cardiovasc Pharmacol 1999; 33:829-35.

  40. Morice MD, Serruys PW, Sousa JE, Fajadet J, Banhayashi E, Perin M. et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-80.

  41. Kirtane AJ, Leon MB, Ball MW et al. The final 5 year follow up from the ENDEAVOUR IV Trial comparing a Zotarolimus eluting stent with a paclitaxel eluting stent. JACC Cardiovasc Interv. 2013; 6:325-333.

  42. Rober L, Magro M, Stefanini GG, et al. Very late coronary stent thrombosis of a newer-generation everolimus eluting stent compared with early-generation drug-eluting stents. A prospective cohort study. Circulation 2012; 125:1110-1121.

  43. Hu T, Yang J, Cui K, Rao Q, Yin T, Tan L, et al. Controlled Slow-Release Drug-Eluting Stents for the Prevention of Coronary Restenosis: Recent Progress and Future Prospects. ACS Appl Mater Interfaces. 2015;7(22):11695–11712. https://www. ncbi.nlm.nih.gov/pubmed/26011753

  44. 16. Chen W, Habraken T, Hennink WE, Kok RJ. Polymer-free drug-eluting stents : an overview of coating strategies and comparison with polymer-coated drug-eluting stents Polymer-free drug-eluting stents : an overview of coating strategies and comparison with polymer-coated drug-eluting stents. Bioconjug Chem. 2015;26(7):1277–1288.

  45. Muramatsu T, Onuma Y, Zhang Y-J, Bourantas C V, Kharlamov A, Diletti R, et al. Progress in treatment by percutaneous coronary intervention: the stent of the future. Rev española Cardiol. 2013;66(6):483–96. https://www.ncbi.nlm.nih.gov/ pubmed/24776051

  46. Echeverri D, Cabrales JR. Terapia de restauración vascular con plataformas biorreabsorbibles. La cuarta revolución. Rev Colomb Cardiol . Sociedad Colombiana de Cardiología y Cirugía Cardiovascular; 2014;21(4):231–40.

  47. Iqbal J, Gunn J, Serruys PW. Coronary stents: Historical development, current status and future directions. Br Med Bull. 2013;106:193–211. https://www.ncbi. nlm.nih.gov/pubmed/23532779.

  48. Campos CM, Muramatsu T, Iqbal J, Zhang YJ, Onuma Y, Garcia-Garcia HM, et al. Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease. Int J Mol Sci. 2013;14:24492–500. http://www.mdpi.com/14220067/14/12/24492.

  49. Bourantas C V., Onuma Y, Farooq V, Zhang Y, Garcia-Garcia HM, Serruys PW. Bioresorbable scaffolds: Current knowledge, potentialities and limitations experienced during their first clinical applications. Int J Cardiol . Elsevier Ireland Ltd; 2013;167(1):11–21. https://www.ncbi.nlm.nih.gov/pubmed/22748288

  50. Simard T, Hibbert B, Ramirez FD, Froeschl M, Chen Y-X, O’Brien ER. The evolution of coronary stents: a brief review. Can J Cardiol . Canadian Cardiovascular Society; 2014;30(1):35–45. https://www.ncbi.nlm.nih.gov/pubmed/24286961

  51. Obregón Santos AG, Aroche Aportela R, Aldama Pérez L, Navas Hernández M, Vila García EE. Ecografía Intracoronaria. Rev Cardiología y Cirugía Cardiovascular 2011;23:3:340-44´

  52. Bach RG, Donohue TJ, Kern MJ, Intracoronary doppler flow velocity measurements for the evaluation and treatment of coronary artery disease. Curr Opin Cardiol 1995; 10:434-42.

  53. Macias E, Medina MA, Gonzalo N, Escaned J. Tomografía de coherencia óptica. Bases y aplicaciones de una nueva técnica de imagen intravascular. Arch Cardiol Mex, 2013;83(2):112-119.

  54. Unzué L et al. Estudio de lesiones coronarias por segmentos mediante TCMD: correlación con el análisis cuantitativo por coronariografía invasiva. Rev Esp Cardiol 2020. https://doi.org/10.1016/j.recesp.2020.04.024.

  55. Palacios IF, Arzamendi, D, Intervencionismo en cardiopatía estructural. Más allá de la terapia valvular transcatéter. Rev. Esp.Cardiol. 2012;65(5):405-413




2020     |     www.medigraphic.com